These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 32802325)

  • 21. A potential association between immunosenescence and high COVID-19 related mortality among elderly patients with cardiovascular diseases.
    Wang Y; Pang SC; Yang Y
    Immun Ageing; 2021 Jun; 18(1):25. PubMed ID: 34074305
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiovascular Disease Risk and Outcomes in Patients Infected With SARS-CoV-2.
    Espinoza D; Jasti M; Malwi UH; Junia C
    Cureus; 2021 Jan; 13(1):e12783. PubMed ID: 33628655
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hydrogen: A Potential New Adjuvant Therapy for COVID-19 Patients.
    Yang F; Yue R; Luo X; Liu R; Huang X
    Front Pharmacol; 2020; 11():543718. PubMed ID: 33178011
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Why the complications of COVID-19 patients differ in elderly and young cancer patients.
    Bravaccini S; Nicolini F; Zanoni M; Gaimari A; Cerchione C; Maltoni R; Pirini F; Mazzotti L; Cortesi M; Ravaioli S; Tumedei MM; Mazza M
    Transl Oncol; 2022 Dec; 26():101541. PubMed ID: 36119944
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical Characteristics and Severity of COVID-19 Disease in Patients from Boston Area Hospitals.
    Dashti HT; Bates D; Fiskio JM; Roche EC; Mora S; Demler O
    medRxiv; 2020 Aug; ():. PubMed ID: 32793930
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Potential Impact of COVID-19 Virus on the Heart and the Circulatory System.
    Alqahtani MS; Abbas M; Alsabaani A; Alqarni A; Almohiy HM; Alsawqaee E; Alshahrani R; Alshahrani S
    Infect Drug Resist; 2022; 15():1175-1189. PubMed ID: 35345472
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiac drug therapy-considerations in the elderly.
    Ayan M; Pothineni NV; Siraj A; Mehta JL
    J Geriatr Cardiol; 2016 Dec; 13(12):992-997. PubMed ID: 28321243
    [TBL] [Abstract][Full Text] [Related]  

  • 28. COVID-19 and cardiovascular problems in elderly patients: Food for thought.
    Costa R; Castagna A; Ruotolo G
    Aging Med (Milton); 2021 Jun; 4(2):146-152. PubMed ID: 33821229
    [TBL] [Abstract][Full Text] [Related]  

  • 29. When Tithonus met corona: the COVID-19 pandemic and acute illness in the elderly.
    Al-Rawi Y
    BMJ Support Palliat Care; 2020 Dec; 10(4):372-373. PubMed ID: 32581005
    [No Abstract]   [Full Text] [Related]  

  • 30. Editorial: Cardioimmunology: Inflammation and Immunity in Cardiovascular Disease.
    Lazzerini PE; Hamilton RM; Boutjdir M
    Front Cardiovasc Med; 2019; 6():181. PubMed ID: 31850376
    [No Abstract]   [Full Text] [Related]  

  • 31. Clinical outcomes of COVID-19 in elderly male patients.
    Sun ZH
    J Geriatr Cardiol; 2020 May; 17(5):243-245. PubMed ID: 32547606
    [No Abstract]   [Full Text] [Related]  

  • 32. Study Aims to Identify Drugs That Could Be Repurposed for COVID-19.
    Rubin R
    JAMA; 2020 Nov; 324(20):2019. PubMed ID: 33231648
    [No Abstract]   [Full Text] [Related]  

  • 33. Health policy implications of the links between cardiovascular risk and COVID-19.
    Singer DR
    Health Policy Technol; 2020 Sep; 9(3):263-265. PubMed ID: 32901219
    [No Abstract]   [Full Text] [Related]  

  • 34. Potential effect of natural and anabolizan steroids in elderly patient with COVID-19.
    Karaahmet F; Karaahmet OZ
    Med Hypotheses; 2020 Apr; 140():109772. PubMed ID: 32344312
    [No Abstract]   [Full Text] [Related]  

  • 35. Implications of Gastrointestinal Involvement in COVID-19.
    Kaur H; Singh A; Gandhi AP; Murugan S; Singh T
    Asia Pac J Public Health; 2020 Nov; 32(8):515-516. PubMed ID: 32865017
    [No Abstract]   [Full Text] [Related]  

  • 36. Editorial: What do we know about COVID-19 implications for cardiovascular disease?
    Wang Z; Tang M; Luan X; Tevaearai Stahel H; Aikawa M; Xie M; Ge S; Zhang S
    Front Cardiovasc Med; 2023; 10():1125655. PubMed ID: 36733303
    [No Abstract]   [Full Text] [Related]  

  • 37. Cellular senescence as a potential mediator of COVID-19 severity in the elderly.
    Nehme J; Borghesan M; Mackedenski S; Bird TG; Demaria M
    Aging Cell; 2020 Oct; 19(10):e13237. PubMed ID: 32955770
    [TBL] [Abstract][Full Text] [Related]  

  • 38. COVID-19 and cardiac injury: clinical manifestations, biomarkers, mechanisms, diagnosis, treatment, and follow up.
    Tajbakhsh A; Gheibi Hayat SM; Taghizadeh H; Akbari A; Inabadi M; Savardashtaki A; Johnston TP; Sahebkar A
    Expert Rev Anti Infect Ther; 2021 Mar; 19(3):345-357. PubMed ID: 32921216
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiac Injury Patterns and Inpatient Outcomes Among Patients Admitted With COVID-19.
    Raad M; Dabbagh M; Gorgis S; Yan J; Chehab O; Dagher C; Jamoor K; Hussein IH; Cook B; Van Harn M; Singh G; McCord J; Parikh S
    Am J Cardiol; 2020 Oct; 133():154-161. PubMed ID: 32829913
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Can COVID 2019 induce a specific cardiovascular damage or it exacerbates pre-existing cardiovascular diseases?
    Mansueto G; Niola M; Napoli C
    Pathol Res Pract; 2020 Sep; 216(9):153086. PubMed ID: 32825954
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.